BioHarvest Sciences
BHST
BioHarvest Sciences (BHST) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.17
- EPS estimate
- −$0.12
- EPS surprise
- −44.68%
- Revenue surprise
- −6.50%
- Revenue
- $8.8M
- Revenue estimate
- $9.5M
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$0.12 | −$0.17 | −44.68% | $8.8M | SEC |
| Q1 2026 | May 14, 2026 | −$0.12 | −$0.11 | +8.33% | $8.5M | SEC |
| Q4 2025 | Mar 31, 2026 | −$0.11 | −$0.10 | +4.76% | $9.1M | — |
| Q3 2025 | Nov 13, 2025 | −$0.12 | −$0.14 | −21.74% | $9.1M | SEC |
| Q2 2025 | Aug 11, 2025 | −$0.11 | −$0.24 | −118.18% | $8.5M | SEC |
| Q1 2025 | May 15, 2025 | −$0.12 | −$0.13 | −8.33% | $7.9M | SEC |
| Q4 2024 | Mar 17, 2025 | −$0.12 | −$0.17 | −37.88% | $7.3M | SEC |
| Q3 2024 | Nov 26, 2024 | −$0.05 | −$0.16 | −220.00% | $6.5M | SEC |
Quarterly revenue
Frequently asked questions
When did BioHarvest Sciences (BHST) last report earnings?
BioHarvest Sciences last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did BHST beat earnings estimates?
No. BioHarvest Sciences reported EPS of −$0.17 for Q2 2026 against a −$0.12 estimate — a 44.68% miss.
How much revenue did BHST report last quarter?
BioHarvest Sciences reported $8.8M in revenue for Q2 2026, against a consensus estimate of $9.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.